Table 2 Effects of CD4 cell count on the willingness of COVID-19 vaccine with HIV infection for 903 subjects in the survey
Variables | Patients, No.(n = 903) | β | S.E | OR | 95% CI | P-Value |
|---|---|---|---|---|---|---|
CD4+T cells count (cells/μL) |  |  |  |  |  |  |
 < 250 | 186 | Ref. |  |  |  |  |
 250–349 | 155 | 0.047 | 0.254 | 1.048 | 0.637–1.723 | 0.854 |
 350–500 | 208 | − 0.210 | 0.229 | 0.810 | 0.518–1.269 | 0.358 |
 > 500 | 334 | − 0.205 | 0.209 | 0.815 | 0.541–1.226 | 0.325 |
 Not done or not available | 20 | − 0.266 | 0.517 | 0.767 | 0.278–2.111 | 0.607 |